V. Miller

ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.

David M. Jones, P. Stephens, G. Frampton, 2017, The oncologist.

RET fusions in a small subset of advanced colorectal cancers at risk of being neglected

A. Drilon, F. Nicolantonio, A. Bardelli, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.

S. Armstrong, A. Ferrando, J. Teruya-Feldstein, 2015, Blood.

Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients

G. Frampton, J. Newberg, E. Golemis, 2019, Nature Communications.

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.

J. Ross, E. Sokol, V. Miller, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.